Get started
Author

Gloribel Bonilla

Observed name: Gloribel A. Bonilla
ORCID: 0000-0003-4272-1191
Observed ORCID: 0000-0003-4272-1191
OpenAlex ID: A5016807790
Adult Circadian Behavior in Drosophila Requires Developmental Expression of cycle, But Not period
2011 · Tadahiro Goda, Karolina Mirowska, et al. · PLoS Genetics · 21
PDF
Disparities in receipt of 1-st line CDK4/6 inhibitors with endocrine therapy for treatment of hormone receptor positive, HER2 negative metastatic breast cancer in the real-world setting
2024 · Asal Pilehvari, Gretchen Kimmick, et al. · Breast Cancer Research · 14
PDF
First- vs second-line CDK 4/6 inhibitor use for patients with hormone receptor positive, human epidermal growth-factor receptor-2 negative, metastatic breast cancer in the real world setting
2024 · Gretchen Kimmick, Asal Pilehvari, et al. · Breast Cancer Research and Treatment · 10
Demographic and clinical characteristics of dominican adults admitted to a diabetic foot clinic in the Dominican Republic, 2015
2019 · Gloribel A. Bonilla, Paige P. Hornsby, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 10
Using the Socio-ecological Model to Explore Facilitators and Deterrents of Tobacco Use Among Airmen in Technical Training
2021 · Kathleen J Porter, Rebecca A Krukowski, et al. · Military Medicine · 8
The Cost-Effectiveness of CDK4/6 Inhibitors in Treating HR+/HER2− Metastatic Breast Cancer Patients in the USA: When Non-medication Expenses are Considered
2025 · Asal Pilehvari, Wen You, et al. · Clinical Drug Investigation · 6
Defining the quality of interdisciplinary care for patients with brain metastases: modified Delphi panel recommendations
2024 · Camilo E Fadul, Jason P Sheehan, et al. · The Lancet Oncology · 6
The Feasibility of Using Self-Generated Identification Codes in Longitudinal Research With Military Personnel
2021 · Melissa A. Little, Gloribel Bonilla, et al. · Evaluation & the Health Professions · 6
Disparities in treatment delays among metastatic breast cancer patients: insights from nationwide electronic health records, 2011–2022
2025 · Asal Pilehvari, Wen You, et al. · Breast Cancer Research and Treatment · 5
Unveiling the cost-effectiveness of CDK4/6 inhibitors in treating patients with HR+/HER2- metastatic breast cancer: A closer look at nonmedication expenses.
2024 · Asal Pilehvari, Wen You, et al. · Journal of Clinical Oncology · 3
The Breast‐Imaging Operations, Practices and Systems Inventory: A framework to examine mammography facility effects on screening in rural communities
2023 · Roger T. Anderson, Marianne M. Hillemeier, et al. · The Journal of Rural Health · 3
PDF
Multi-Pronged Solutions Addressing Barriers to Breast Screening Access in Appalachia
2024 · Cara Brooks Safon, George Batten, et al. · American Journal of Qualitative Research · 2
PDF
Cancer Prevention from the Viewpoint of UVA Comprehensive Cancer Center
2022 · Thomas P. Loughran, Wendy Cohn, et al. · Cancer Prevention Research · 2
PDF
Digital Breast Tomosynthesis Use, Facility Mammography Volume, and Timely Follow‐Up After Abnormal Screening Mammograms in Appalachia, United States
2026 · Silas Selorm Daniels‐Donkor, Fabian T. Camacho, et al. · The Journal of Rural Health
PDF
Clinical and Demographic Characteristics of Patients With Long-Term Disease Control With First-Line Endocrine Therapy Alone for Hormone Receptor Positive, HER2 Negative, Metastatic Breast Cancer
2026 · Gretchen Kimmick, Asal Pilehvari, et al. · Clinical Breast Cancer
Less Time Toxicity from Health Care as a Benefit of Palliative Care among Patients with Brain Metastases
2026 · Roger Anderson, Gloribel Bonilla, et al. · Journal of Pain and Symptom Management
Patient, facility, and community determinants of timely follow up after abnormal screening mammograms in Appalachia: A multilevel analysis
2026 · Roger T. Anderson, Marianne M. Hillemeier, et al. · The Journal of Rural Health
PDF
Clinical and demographic characteristics of long-term responders to first-line endocrine therapy alone for hormone receptor positive, HER2 negative, metastatic breast cancer
2026 · Gretchen G. Kimmick, Asal Pilehvari, et al. · SSRN Electronic Journal
Area deprivation index as a predictor of survival and treatment disparities in older adults with Acute Myeloid Leukemia: A population-based Study
2025 · Valerie Tran, Gloribel Bonilla, et al. · Blood
PDF
Supc-03 Quality of Life Goals and Factors Influencing Qol Among Patients Diagnosed With Brain Metastases and Their Caregivers: a Multi-site Qualitative Study
2025 · Kathleen J Porter, Camilo E Fadul, et al. · Neuro-Oncology Advances
PDF
Dsai-09 Applying Consensus Quality of Care Measures for Brain Metastases (bmets-qc) to Patient Ehr Data, a Pilot Study
2024 · Roger Anderson, Gloribel Bonilla, et al. · Neuro-Oncology Advances
Qspc-09 Factors Impacting Quality of Life After Brain Metastases Diagnosis: a Mixed Methods Study of Patients and Their Caregivers
2024 · Kathleen Porter, Caroline Mulligan, et al. · Neuro-Oncology Advances
Abstract PO1-17-12: The impact of treatment sequence of CDK4/6 inhibitor therapy on Metastatic Breast Cancer treatment outcomes in Real-World practice in U.S
2024 · Gretchen Kimmick, Asal PIlehvari, et al. · Cancer Research
The real-world modeling of benefits demonstrated in major clinical trials on 2 HR+/HER2− metastatic breast cancer treatment with CDK4/6 inhibitor in the US: PALOMA-2 and MONALEESA-3.
2023 · Asal Pilehvari, Gretchen Genevieve Kimmick, et al. · Journal of Clinical Oncology
PDF
Works count: 24
Citation count: 96
H-index: 6
I10-index: 4
Year
Topic
Type